PWAG
ARNA

Polaris Wealth Advisory Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Polaris Wealth Advisory Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,674
Closed -$95K – 123
2016
Q4 		$95K Buy
+6,674
New +$103K 0.01% 110

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Polaris Wealth Advisory Group's ARNA Position: Q1 2017 in Review

Polaris Wealth Advisory Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2017, closing a stake of 6,674 shares — an estimated $95K sold.

Polaris Wealth Advisory Group first reported a position in ARNA in Q4 2016 and held it in 1 quarter. The position peaked at $95K in Q4 2016. 126 funds tracked by Wall St. Rank hold ARNA as of Q1 2017.

  • Polaris Wealth Advisory Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Polaris Wealth Advisory Group sold 6,674 Arena Pharmaceuticals Inc shares in Q1 2017, an estimated $95K.
  • Polaris Wealth Advisory Group first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
  • Polaris Wealth Advisory Group's Arena Pharmaceuticals Inc position peaked at $95K in Q4 2016.
  • 126 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2017.

Based on Polaris Wealth Advisory Group's 13F filing for Q1 2017, filed 26 Apr 2017.